PCOS Is a Metabolic Condition: Insulin Resistance in 2026

Most people meet PCOS through a missed period, stubborn acne, or unwanted hair growth. So it tends to get filed under "a period problem" or "a fertility problem." The research of the past few years points somewhere different. Polycystic ovary syndrome behaves like a whole-body metabolic condition, and for many people the reproductive symptoms are the visible surface of something happening deeper, in how the body handles insulin and stores fat.

That reframing matters because it changes what good care looks like. If PCOS is mostly about the ovaries, you watch your cycle and move on. If it is a metabolic condition, then your blood sugar, your liver, your cholesterol, and your blood pressure all deserve attention too, often years before any of them would otherwise be checked.

What PCOS actually is

PCOS is a common hormonal condition, affecting a large share of people of reproductive age worldwide. Diagnosis usually rests on a combination of irregular or absent ovulation, signs of higher androgen levels (such as acne or excess hair), and the appearance of many small follicles on the ovaries. You do not need all three features to be diagnosed.

The name itself is under active debate. In 2026 an international push gathered momentum to rename the condition to better reflect its metabolic nature, with "PMOS" among the proposals. We cover that conversation in detail in our companion post on whether PCOS is being renamed to PMOS, and how it sits alongside other commonly confused conditions in our comparison of PCOS, PMOS, endometriosis, and adenomyosis. Whatever it ends up being called, the underlying biology is the point of this article.

The insulin-resistance engine, explained simply

Insulin is the hormone that tells your cells to take sugar out of the blood and use it for energy. In insulin resistance, your cells stop responding well to that signal. Your pancreas compensates by pumping out more insulin to get the same job done, so you end up with high circulating insulin, a state called hyperinsulinemia.

Estimates vary by how it is measured, but insulin resistance is reported in a large majority of people with PCOS, with figures across studies ranging from roughly 35 percent to 80 percent. Crucially, it is not just a feature of higher body weight. Lean people with PCOS can be insulin resistant too, which suggests the resistance is part of the condition itself rather than simply a side effect of carrying extra weight.

Here is the loop that ties it back to your cycle. High insulin pushes the ovaries to make more androgens (male-type hormones like testosterone). It also lowers a carrier protein called sex hormone-binding globulin, which frees up even more active androgen. Those raised androgens interfere with ovulation, which is what produces the irregular periods, the acne, and the excess hair. So the same insulin signal that strains your metabolism is also driving the symptoms you actually notice. That is why treating the metabolism can improve the periods, and why ignoring the metabolism leaves the root cause untouched.

The metabolic risks worth knowing

Because high insulin is a constant low-grade stress on the body, PCOS carries a measurably higher risk of several long-term conditions. These are risks, not certainties, and they are strongly modifiable, but they are real enough that guidelines now recommend actively screening for them.

Type 2 diabetes. This is the best-established link. People with PCOS have roughly a four- to eightfold higher risk of type 2 diabetes compared with peers of similar age and weight, and some research suggests up to around 10 percent develop type 2 diabetes by age 40. Impaired glucose tolerance, the stage before diabetes, is also more common.

Fatty liver disease (MASLD). This is the link the newest research is sharpening. Metabolic dysfunction-associated steatotic liver disease, or MASLD (the updated name for non-alcoholic fatty liver disease), is when fat builds up in the liver in a way tied to metabolic problems rather than alcohol. A systematic review and meta-analysis pooling 36 studies found a NAFLD prevalence of about 43 percent among people with PCOS, which is strikingly high given how young the average study participant was. The same analysis found the risk tracked with insulin resistance, higher androgen levels, and metabolic syndrome.

Metabolic syndrome and dyslipidemia. Metabolic syndrome is a cluster of findings (raised waist circumference, high blood pressure, high blood sugar, high triglycerides, low HDL cholesterol) that together raise heart and diabetes risk. An unfavorable cholesterol pattern, with high triglycerides and low protective HDL, is reported in a large share of people with PCOS.

Cardiovascular risk. Carrying insulin resistance, an adverse lipid profile, and higher rates of high blood pressure for decades adds up. PCOS is associated with raised cardiovascular risk factors, and hypertension appears more often than in the general population. The long game of PCOS care is partly about protecting the heart and blood vessels over a lifetime.

What the 2026 research shows

A few threads from recent work are reshaping the picture.

The first is the liver. Researchers at UCSF are running longitudinal work asking why young people with PCOS have such a high rate of fatty liver, and specifically whether androgens themselves drive liver injury. Their studies compare how liver fat changes over time in people with and without PCOS, and probe whether visceral fat and lipid handling, or the androgens directly, are the bigger culprit. The aim is precision: figuring out which lever actually moves liver disease in this group, which could eventually point to more targeted treatment. This is investigational, not settled, but it signals that the field now treats the liver as a core PCOS organ, not an afterthought.

The second is scale. Global burden analyses using the Global Burden of Disease 2021 data estimate tens of millions of people living with PCOS worldwide, on the order of 65 to 70 million cases, with prevalence among people of childbearing age rising sharply (by close to 90 percent) since 1990. Part of that is better recognition and diagnosis, but it underlines that this is a large and growing population whose metabolic health is at stake.

The third is the steady accumulation of evidence that the reproductive and metabolic sides of PCOS are not separate problems to be managed by separate specialists, but two expressions of the same underlying insulin and androgen biology.

What this means for you

If you have PCOS, the practical takeaway is not to panic about any single statistic. It is to widen the lens. Two people can both have "PCOS" and have very different metabolic profiles, so the goal is to know yours. A person with clear insulin resistance and rising liver markers needs a different plan from someone whose main concern is fertility and whose metabolic markers are clean. Knowing where you sit lets you and your clinician focus effort where it actually helps.

What to do: a doctor-ready checklist

None of the following is a substitute for individual medical advice, and medication choices in particular are decisions for you and your clinician. But these are reasonable things to raise.

1. Ask for metabolic screening, not just a cycle check. Current international guidance recommends checking glucose handling in people with PCOS, typically with a fasting glucose, an HbA1c, or an oral glucose tolerance test, and repeating it periodically rather than once. Ask how often you should be retested given your own risk factors.

2. Ask about your lipids and blood pressure. A fasting lipid panel and regular blood pressure checks help catch the cardiovascular side early, when lifestyle change does the most good.

3. Ask whether your liver should be assessed. Given the high rate of fatty liver in PCOS, it is reasonable to ask whether liver enzymes or imaging are warranted, especially if you also have insulin resistance, higher androgens, or extra weight around the middle.

4. Make lifestyle the foundation. Guidelines place healthy eating, regular physical activity, and sleep at the base of PCOS management for everyone, regardless of weight, because they improve insulin sensitivity directly. Even modest, sustainable changes can shift the metabolic picture and improve cycle regularity.

5. Discuss medication options as a clinician decision. Several are used, each with caveats:

   • Metformin improves insulin sensitivity and is often considered for metabolic features or to support cycle regularity. It is a prescription decision based on your profile.
   • Inositol (myo-inositol, sometimes with D-chiro-inositol) is a popular supplement studied for insulin and ovulation in PCOS, but the quality of evidence is still limited and guidelines stop short of a strong recommendation. Treat it as something to discuss, not a guaranteed fix.
   • GLP-1 receptor agonists (the newer weight and glucose medications) are increasingly used where weight and metabolic risk are central concerns, but they are not a first-line PCOS treatment, carry their own considerations, and are not appropriate for everyone, especially anyone who may become pregnant. This is firmly a conversation to have with a prescriber.

The throughline: ask to be assessed as a metabolic patient, then build the plan from there.

Signs of insulin resistance to watch for

Insulin resistance does not announce itself, but some patterns can be hints worth mentioning to your clinician:

• Darkened, velvety patches of skin, often on the neck, armpits, or groin (called acanthosis nigricans)
• Skin tags
• Strong sugar or carbohydrate cravings, or feeling shaky and hungry a few hours after eating
• Fat that settles around the middle
• Persistent fatigue, especially after meals
• Worsening acne or excess hair alongside irregular cycles

None of these confirms insulin resistance on its own, and you can have insulin resistance without obvious signs, which is exactly why bloodwork matters.

How Femora helps

Femora is built to give you the kind of longitudinal picture that PCOS care depends on. Irregular and unpredictable cycles are one of the hallmarks of PCOS, and they are also hard to characterize from memory in a short appointment. Tracking your cycles and symptoms over months turns vague impressions into a record you can actually show a clinician.

If you are not sure whether your pattern fits PCOS in the first place, our PCOS symptom checker walks you through the common features so you can have a more informed conversation. Because body composition is one input into metabolic risk, our BMI calculator gives you a quick piece of context to bring along, with the caveat that BMI is only one rough signal and never the whole story. And for ongoing tracking tailored to this condition, Femora's PCOS mode is designed around irregular cycles and the symptom patterns that matter for PCOS.

The app does not diagnose or treat anything. What it does is help you arrive at your appointment with data instead of guesswork, which is half the battle when a condition is this individual.

The bigger picture

The most useful shift in thinking about PCOS is to stop seeing it as a switch that is either on or off in the ovaries, and start seeing it as a dial on your whole metabolism that has been turned up. That framing is more demanding, because it asks you to care about your liver and your blood sugar in your twenties and thirties, not just your period. But it is also more hopeful, because the metabolic dial responds to the things you can influence: what you eat, how you move, how you sleep, and the treatments you and your clinician choose together. The risks are real, and they are also among the most modifiable in medicine.

Understand the engine, and the whole condition becomes easier to manage.

Download Femora to track your cycle and symptoms and bring a clearer picture to your next appointment.

Sources